Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Rifaximin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rifaximin 550mg tablets
0501070X0AAABAB
|
Rifaximin | Rifaximin | Infections | 34,286 |
|
Rifaximin 200mg tablets
0501070X0AAAAAA
|
Rifaximin | Rifaximin | Infections | 594 |
|
Targaxan 550mg tablets
0501070X0BEAAAB
|
Targaxan | Rifaximin | Infections | 339 |
|
Xifaxanta 200mg tablets
0501070X0BCAAAA
|
Xifaxanta | Rifaximin | Infections | 13 |
|
Rifaximin 100mg/5ml oral suspension
0501070X0AAACAC
|
Rifaximin | Rifaximin | Infections | 2 |
|
Normix 100mg/5ml granules for oral suspension
0501070X0BBABAC
|
Normix | Rifaximin | Infections | No data available |
|
Normix 200mg tablets
0501070X0BBAAAA
|
Normix | Rifaximin | Infections | No data available |
|
Xifaxan 550mg tablets
0501070X0BDAAAB
|
Xifaxan | Rifaximin | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.